Life sciences Life sciences Geneva start-up STALICLA signs exclusive in-licensing agreement with Novartis 16 January 2023
Life sciences Geneva biopharma ObsEva sells its Ebopiprant license for up to USD 113 million 23 November 2022
Life sciences Sophia Genetics partners with Microsoft to accelerate health data analysis 8 November 2022
Life sciences Idiap and InflamAlps partner up to accelerate antibiotic research using artificial intelligence 25 October 2022
Life sciences Cordis to acquire Vaud-based medtech MedAlliance for up to USD 1.1 billion 24 October 2022